{"id":15900,"date":"2018-11-13T10:54:40","date_gmt":"2018-11-13T10:54:40","guid":{"rendered":"https:\/\/celonpharma.com\/?p=15900"},"modified":"2018-11-13T10:54:40","modified_gmt":"2018-11-13T10:54:40","slug":"dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/","title":{"rendered":"Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d"},"content":{"rendered":"

On 16 November this year, \u00a0President of the Management Board of Celon Pharma S.A. will give a lecture discussing the discovery and implementation of innovations in the pharmaceutical sector on the example of drug candidates developed under Celon Pharma\u2019s clinical programmes. He will also participate in an expert debate entitled: \u201cBusiness for science\u201d.<\/p>\n

We encourage you to take part in the event.<\/p>\n","protected":false},"excerpt":{"rendered":"

On 16 November this year, \u00a0President of the Management Board of Celon Pharma S.A. will give a lecture discussing the discovery and implementation of innovations in the pharmaceutical sector on the example of drug candidates developed under Celon Pharma\u2019s clinical programmes. He will also participate in an expert debate entitled: \u201cBusiness for science\u201d. We encourageRead more »<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-15900","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"\nMaciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"On 16 November this year, \u00a0President of the Management Board of Celon Pharma S.A. will give a lecture discussing the discovery and implementation of innovations in the pharmaceutical sector on the example of drug candidates developed under Celon Pharma\u2019s clinical programmes. He will also participate in an expert debate entitled: \u201cBusiness for science\u201d. We encourageRead more »\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-13T10:54:40+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/\",\"url\":\"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/\",\"name\":\"Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2018-11-13T10:54:40+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/","og_locale":"en_US","og_type":"article","og_title":"Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d - CelonGROUP","og_description":"On 16 November this year, \u00a0President of the Management Board of Celon Pharma S.A. will give a lecture discussing the discovery and implementation of innovations in the pharmaceutical sector on the example of drug candidates developed under Celon Pharma\u2019s clinical programmes. He will also participate in an expert debate entitled: \u201cBusiness for science\u201d. We encourageRead more »","og_url":"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/","og_site_name":"CelonGROUP","article_published_time":"2018-11-13T10:54:40+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/","url":"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/","name":"Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2018-11-13T10:54:40+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2018\/11\/13\/dr-maciej-wieczorek-o-strategiach-rozwoju-lekow-innowacyjnych-na-xi-multidyscyplinarnej-konferencji-nauki-o-leku-nauka-dla-przemyslu-przemysl-dla-nauki\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science \u201cScience for the Industry, Industry for science\u201d"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=15900"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15900\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=15900"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=15900"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=15900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}